News
GlobalData on MSN9h
Arrowhead sells China hypertriglyceridemia candidate rights to SanofiArrowhead Pharmaceuticals’ subsidiary Visirna Therapeutics has entered an asset purchase agreement with Sanofi for the rights ...
Zacks Investment Research on MSN3h
Sarepta to Report Q2 Earnings: What's in Store for the Stock?We expect Sarepta Therapeutics SRPT to report second-quarter 2025 earnings on Aug. 6, after market close. The company’s ...
Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.
The importance of China as a growth market for pharma multinationals is underlined by the news that Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug under review for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback